Definium Therapeutics, Inc
Financing
SEC filings to 2026-10-05 · every row opens its filingShares on issue
134.4M
on 2026-06-30, from 71.2M on 2024-03-31 10-Q ↗
a raise that quarter, at its price
Newest
S-3ASR of 2024-06-28. Not read yet. S-3ASR ↗
5 of its filings are not read yet.
Warrants
The 10-Q filed 2026-08-06 is not read yet.
Cash
25.8 quarters
$1.08B on 2026-06-30 ÷ $42.0M a quarter of operating cash used, the average of four quarters. 10-Q ↗
| Date | What | Shares | Price | Gross | Filing |
|---|---|---|---|---|---|
| 2026-06-23 | Public offering | 20,588,236 | $34.00 | $700.0M | 424B5 ↗ |
| 2025-10-29 | Public offering | 18,375,000 | $12.25 | $225.1M | 424B5 ↗ |
Also on file: up to $50.0M term loans agreed 2025-04-18 8-K ↗